ReviewEuropean respiratory review : an official journal of the European Respiratory Society2021
Contemporary issues in the implementation of lung cancer screening.
Review in European respiratory review : an official journal of the European Respiratory Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.
- Shared decision-making in the management of pulmonary nodules: a systematic review of quantitative and qualitative studies.BMJ open · 2024Pooled it
- Lung cancer screening primer: Key information for primary care providers.Canadian family physician Medecin de famille canadien · 2021Trial
- Robotic-assisted bronchoscopy combined with digital tomosynthesis for pulmonary nodules characterization: a single center experience.Frontiers in medicine · 2026Article
- The probability of lung cancer in patients with pulmonary nodules detected via low-dose computed tomography screening in China.BMC cancer · 2025Article
- Screening for Lung Cancer, Overdiagnosis, and Healthcare Utilization: A Nationwide Population-Based Study.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025Article
- Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer.Nature communications · 2025Article
- Clinical Value of Low-Dose Spiral CT Combined with Serum CEA in the Differential Diagnosis of Early Lung Cancer.Cancer management and research · 2025Article
- Pulmonologists-level lung cancer detection based on standard blood test results and smoking status using an explainable machine learning approach.Scientific reports · 2024Article
- Res-TransNet: A Hybrid deep Learning Network for Predicting Pathological Subtypes of lung Adenocarcinoma in CT Images.Journal of imaging informatics in medicine · 2024Article
- Value of ultrathin bronchoscope in improving the endobronchial ultrasound localization rate and diagnosing peripheral pulmonary nodules by cryobiopsy.BMC pulmonary medicine · 2024Article
- Retrospective evaluation of plasma protein tumour markers for early lung cancer detection.BJC reports · 2024Article
- About cancer screenings and saving lives: measuring the effects of cancer screening programs through meta-analyses-A comment to the meta-analysis "Estimated Lifetime Gained With Cancer Screening Tests" by Bretthauer et al. (2023).Frontiers in public health · 2024Article
- Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study.International journal of cancer · 2024Article
- Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024Review
- Circulating proteome for pulmonary nodule malignancy.Journal of the National Cancer Institute · 2023Article
- Could DNA Fragments Be the Key to Early Detection of Lung Cancer?American journal of respiratory and critical care medicine · 2023Article
- Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives.Molecular biology reports · 2023Review
- Interventions Designed to Increase the Uptake of Lung Cancer Screening: An Equity-Oriented Scoping Review.JTO clinical and research reports · 2023Article
- Article
- Predictive value of the resistance of the probe to pass through the lesion in the diagnosis of peripheral pulmonary lesions using radial probe endobronchial ultrasound with a guide sheath.Frontiers in oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer screening with low-dose computed tomography can reduce death from lung cancer by 20-24% in high-risk smokers. National lung cancer screening programmes have been implemented in the USA and Korea and are being implemented in Europe, Canada and other countries. Lung cancer screening is a process, not a test. It requires an organised programmatic approach to replicate the lung cancer mortality reduction and safety of pivotal clinical trials. Cost-effectiveness of a screening programme is strongly influenced by screening sensitivity and specificity, age to stop screening, integration of smoking cessation intervention for current smokers, screening uptake, nodule management and treatment costs. Appropriate management of screen-detected lung nodules has significant implications for healthcare resource utilisation and minimising harm from radiation exposure related to imaging studies, invasive procedures and clinically significant distress. This review focuses on selected contemporary issues in the path to implement a cost-effective lung cancer screening at the population level. The future impact of emerging technologies such as deep learning and biomarkers are also discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.